Treatment of intracranial metastases is mostly based on comprehensive treatment, supplemented by radiation therapy (including gamma knife, X-knife, radio-wave knife, etc.) and chemotherapy, which can relieve patients’ symptoms and prolong their lives. Surgical treatment includes tumor resection and palliative or decompression surgery. For single metastatic tumor in the brain, if the general condition is good, the primary tumor has been resected and no other metastasis is found, tumor resection can be performed. If the primary tumor has not been resected but can be removed, and the brain symptoms, especially the symptoms of increased intracranial pressure, are significant, brain tumor resection can be performed first. After the increase of intracranial pressure is relieved, resection of the primary tumor can be performed again. When removing the tumor, it is generally easy to separate from the brain tissue, and the scope of resection should be more extensive, striving for total resection. If the tumor site is deep or multiple tumors, as well as meningeal metastasis, decompression surgery can be performed to reduce the symptoms. As for those whose primary tumor cannot be resected, who have multiple metastases in the body and whose general condition is very poor, surgery is not recommended. Hormones, dehydrating drugs and symptomatic treatment can be given to relieve the symptoms for a short period of time. Those with better general condition and normal blood picture after surgery. Radiation therapy can be given to those who cannot be resected without multiple metastases, and radiation therapy can also be performed. For nasopharyngeal tumor and other invasive tumors that are not suitable for surgery, radiation therapy is appropriate. Chemotherapy can also be given to those with normal blood and liver and kidney functions. Carazepam, cyclohexylnitrosourea and anti-cancer drugs can be given according to the type of primary tumor. In the spirit of providing the best medical service for all patients, the neurological ward 2 of Sanbo Brain Hospital of Capital Medical University has taken advantage of the department’s strengths to provide the best medical service. Under the leadership of doctors Yu Chunjiang, Zhang Hongwei, Zhang Mingshan, Ren Ming, Xia Lei, Qu Yanming, Wang Haoran and Gu Chunyu, who are all members of the neurosurgery team, there have been no medical complaints for 2 consecutive years. The advantages of intracranial metastatic cancer in Sanbo Brain Hospital of Capital Medical University: 1. The intracranial tumor ward is divided into surgical group and chemotherapy group, and there are 8 neurosurgeons in the surgical group and 2 oncologists in the chemotherapy group. We are equipped with advanced diagnostic and therapeutic equipment for cranial surgery, such as magnetoencephalography, magnetic resonance imaging and other diagnostic equipment, as well as intraoperative navigation, intraoperative ultrasound and intraoperative electrophysiological monitoring, which can improve the rate of total tumor resection and reduce surgical complications. 3.Patients with intracranial metastatic cancer can get comprehensive treatment plan in our department. There are senior professors to guide radiotherapy and make radiotherapy plan, and physicians of chemotherapy group can help guide patients with intracranial metastatic cancer for further treatment after surgery. 4. At the same time, our hospital can conduct molecular pathology testing for metastatic cancer pathology, which provides important basis for guiding chemotherapy targeted drug treatment.